Literature DB >> 11158424

Polycystic kidney patient as a cadaveric donor: is it appropriate?

Y S Shan1, P C Lee, E D Sy, C J Hung, Y J Lin.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11158424     DOI： 10.1093/ndt/16.2.410

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level?

Authors:  G Canaud; B Knebelmann; P C Harris; F Vrtovsnik; J-M Correas; N Pallet; C M Heyer; E Letavernier; F Bienaimé; E Thervet; F Martinez; F Terzi; C Legendre
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

2.  Marginal donor kidney in a marginal recipient: Five year follow-up.

Authors:  M M Bahadur; P Binnani; R Gupta; S Pattewar
Journal:  Indian J Nephrol       Date:  2010-04

3.  Inadvertent transmission of polycystic kidney disease in kidney transplantation.

Authors:  Amit Langote; Andrea Mazarova; John Mahoney; Brian Blew; Greg A Knoll
Journal:  Am J Case Rep       Date:  2015-02-26

4.  Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana.

Authors:  Perditer Okyere; Richard K D Ephraim; Isaac Okyere; Joseph Attakorah; Dorcas Serwaa; Grace Essuman; Albert Abaka-Yawson; Prince Adoba
Journal:  BMC Nephrol       Date:  2021-04-28       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.